Interim Results

AI SummaryClose X

ANGLE plc reported interim results for the six months ended June 30, 2025, with revenues of £0.8 million, down from £1.0 million in H1 2024. Pharma services revenue was £0.3 million (H1 2024: £0.5 million), while product-related revenue remained steady at £0.5 million. The loss for the half-year was £9.3 million, or 2.87 pence per share, compared to a loss of £7.7 million, or 2.89 pence per share, in H1 2024. Operating costs, excluding non-cash foreign exchange movements, decreased by 12% to £8.0 million. Cash and cash equivalents stood at £5.3 million at the end of June, down from £10.4 million at the end of December 2024, with R&D Tax Credits due of £1.3 million. The company anticipates revenues for 2025 to exceed £1.5 million.

Disclaimer*

UK 100

Latest directors dealings